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Abstract
Group A rotaviruses (RV-A) are the leading cause of viral gastroenteritis in children worldwide 
and genotype G9P[8] is one of the five most common genotypes detected in humans. In order to 
gain insight into the degree of genetic variability of G9P[8] strains circulating in Cameroon, stool 
samples were collected during the 1999–2000 rotavirus season in two different geographic regions 
in Cameroon (Southwest and Western Regions). By RT-PCR, 15 G9P[8] strains (15/89 = 16.8%) 
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were identified whose genomic configurations was subsequently determined by complete or 
partial gene sequencing. In general, all Cameroonian G9 strains clustered into current globally-
spread sublineages of the VP7 gene and displayed 86.6–100% nucleotide identity amongst 
themselves and 81.2–99.5% nucleotide identity with global G9 strains. The full genome 
classification of all Cameroonian strains was G9-P[8]-I1–R1–C1–M1–A1–N1–T1–E1–H1 but 
phylogenetic analysis of each gene revealed that the strains were spread across 4 or more distinct 
lineages. An unusual strain, RVA/Human-wt/CMR/6788/1999/G9P[8], which shared the genomic 
constellation of other Cameroonian G9P[8] strains, contained a novel G9 subtype which diverged 
significantly (18.8% nucleotide and 19% amino acid distance) from previously described G9 
strains. Nucleotide and amino acid alignments revealed that the 3′ end of this gene is highly 
divergent from other G9 VP7 genes suggesting that it arose through extensive accumulation of 
point mutations. The results of this study demonstrate that diverse G9 strains circulated in 
Cameroon during 1999–2000.
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1. Background
Childhood mortality has been declining worldwide as a result of socioeconomic 
development and implementation of prevention and survival interventions (Claeson et al., 
2000). Group A rotaviruses (RV-A) are the main etiologic agent of acute gastroenteritis in 
infants and young children worldwide (Estes and Kapikian, 2007) and an estimated 453,000 
children aged <5 years die from rotavirus diarrhea each year, with >85% of these deaths 
occurring in low-income countries of Africa and Asia (Parashar et al., 2009; Tate et al., 
2011). Rotaviruses belong to the family Reoviridae, and the rotavirus genome consists of 11 
double-stranded RNA gene segments that encode six structural (VP) and six non-structural 
proteins (NSP). Based on the two genes that encode the outer capsid proteins, VP4 (P-type) 
and VP7 (G-type), a widely used binary classification system was established for RV-A 
(Estes and Kapikian, 2007). This system has been recently standardized and extended to all 
11 genes (Matthijnssens et al., 2008b). To date, at least 27 G, 35 P, 16 I, 9 R, 9 C, 8 M, 16 
A, 9 N, 12 T, 14 E and 11 H genotypes have been identified based on the eleven rotavirus A 
genes (Esona et al., 2010b; Matthijnssens et al., 2011). In humans, at least five RV-A G 
types (G1–G4 and G9), and two common P types (P[8] and P[4]) circulate worldwide 
(Banyai et al., 2012; Gentsch et al., 2005; Santos and Hoshino, 2005). G9 strains emerged in 
1990s, and there has been a global description of the appearance and dominance of this 
genotype (Gentsch et al., 2005; Laird et al., 2003; Matthijnssens et al., 2009; Santos and 
Hoshino, 2005). Genotype G9 strains with a Wa-like or a DS-1-like genomic configuration 
or a mixture thereof have been detected sporadically in localized outbreaks (Page et al., 
2010). In Cameroon, the first molecular identification of genotype G9 in human samples 
was reported in a study conducted by Steele and colleagues in 2003 (Steele and Ivanoff, 
2003).
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At least seven major phylogenetic lineages and eleven minor lineages within G9 VP7 genes 
have been described (Phan et al., 2007; Wu et al., 2011). A molecular evolutionary analysis 
study utilizing Bayesian inference supported the idea that one single sub-lineage introduced 
in the 1980s was responsible for all the worldwide spread of G9 in the 1990s (Matthijnssens 
et al., 2010).
In order to gain insight into the degree of genetic variability of G9P[8] strains circulating in 
Cameroon, Central Africa, sequence determination and phylogenetic analysis of all eleven 
genome segments from G9P[8] RV-A strains detected in two different geographic regions of 
Cameroon (Southwest and Western Regions) was performed in order to infer the genetic 
relationship of Cameroonian strains with G9P[8] worldwide. The results of these studies 
revealed a new G9 genetic variant circulating in Cameroon during the 1999–2000 rotavirus 
seasons.
2. Material and methods
2.1. Fecal samples, strains and nomenclature
Fifteen diarrheic stool specimens collected from children <5 years of age, genotyped as 
G9P[8] (Esona et al., 2010a), were obtained during the 1999–2000 rotavirus season in two 
different geographic regions in Cameroon (Southwest and Western Regions). The strains 
and nomenclature are shown in Table 1.
2.2. Viral RNA extraction, amplification, and sequencing
Viral RNA from each of the 15 specimens was extracted from a 10% stool suspension made 
from 0.1 g or 100 μl stool in 2 ml of a 1:1 Vertrel/Water solution using either a commercial 
RNA extraction kit (NucliSens automated extractor, BIOMERIEUX, Durham, NC) 
according to the protocol specified by the manufacturer or a silica binding method described 
previously (Boom et al., 1990).
Previously published forward and reverse primers (Das et al., 1994; Gentsch et al., 1992; 
Iturriza-Gomara et al., 2001, 2002; Kerin et al., 2007; Matthijnssens et al., 2006; Mijatovic-
Rustempasic et al., 2011) were used for the amplification of the different gene segments. 
The extracted dsRNA of each strain was denatured at 97 °C for 5 min and RT-PCR was 
carried out using a one step RT-PCR kit (Qiagen, Inc., Valencia, CA) according to 
manufacturer’s instructions. Reverse transcription (RT) of each gene from each sample was 
carried out for 30 min at 42 °C, followed by 15 min at 95 °C to inactivate the reverse 
transcriptase and activate the Taq polymerase. The cDNA was then subjected to 35 cycles of 
PCR in a GeneAmp PCR System 9700 thermal cycler (Applied Biosystems, Inc., Foster 
City, CA) using the following conditions: 30 s at 94 °C; 30 s at 42 °C; 45–90 s at 72 °C 
(depending upon the expected size of the amplified gene fragment), followed by a 7 min 
final extension at 72 °C. Amplicons were analyzed by gel electrophoresis in 1% SeaKem 
agarose gels (Thermo Fisher Scientific, Inc., Waltham, MA) then excised and purified with 
the QIAquick Gel Extraction kit (Qiagen, Inc., Valencia, CA) following the manufacturer’s 
instructions.
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DNA cycle sequencing of each amplicon was performed with the same consensus primers 
used for RT-PCR, using a Big Dye Terminator cycle sequencing Ready kit v1.1 (Applied 
Biosystems, Inc., Foster City, CA). Previously published primers homologous to internal 
regions of each gene segment were also used (Mijatovic-Rustempasic et al., 2011). Cycle 
sequencing products were purified using Centri-sep spin columns (Princeton Separations, 
Inc., Adelphia, NJ), dried in a DNA speed VacR (Savant Instruments, Inc., Holbrook, NY) 
and reconstituted in 15 ml Hi-Di formamide. Automated separation and base-calling of cycle 
sequencing products was performed using an ABI 3130xl sequencer (Applied Biosystems, 
Foster City, CA). Overlapping sequence fragments were assembled and edited using 
Sequencher 4.8 (Gene Codes Corporation, Inc., Ann Arbor, MI).
2.3. Computational analysis
Sequences were aligned using the MUSCLE program within MEGA version 5 (Tamura et 
al., 2011). Once aligned, the JModel-Test 2 program (Posada, 2008) was used to identify the 
optimal evolutionary model that best fitted the sequence datasets. Using corrected Akaike 
Information Criterion (AICc) the following models; TPM3uf + I + G (NSP1), TIM2 + I + G 
(NSP2), GTR + I + G (NSP3, VP1, VP2, VP6), HKY + G (NSP4), TVM + G (NSP5), TIM3 
+ I + G (VP3), TPM1uf + G (VP4), and TPM3uf + G (VP7) were found to best fit the 
sequence data for the different genes. Using these models, maximum likelihood trees were 
constructed using PhyML 3.0 along with approximate likelihood-ratio test (aLRT) statistics 
for branch support (Guindon et al., 2010). Nucleotide and amino acid distance matrixes were 
prepared using the p-distance algorithm of MEGA version 5 software (Tamura et al., 2011).
Using the crystal structure of the RRV VP7 protein (PDB accession number 3fmg; (Aoki et 
al., 2009), amino acid substitutions found in Cameroonian strain RVA/Human-wt/CMR/
6788/1999/G9P[8] were mapped spatially onto the 3D protein structure using the PyMOL 
Molecular Graphics System, version 1.5.0.1 (Schrodinger, 2010).
3. Results
3.1. The genotype configuration of Cameroonian G9P[8] strains
The names and characteristics of the Cameroonian strains analyzed in this study, and lengths 
of each gene are presented in Table 1. The accession numbers of each gene of the 
Cameroonian G9 strains and those from the GenBank are in the appendix. Accession 
numbers in bold face characters represent the gene sequences of these Cameroon G9 strains. 
Nucleotide sequences analysis based on VP7–VP4–VP6–VP1–VP2–VP3–NSP1–NSP2–
NSP3–NSP4–NSP5 genes from all Cameroonian samples analyzed revealed a consensus 
genotype constellation of G9-P[8]-I1–R1–C1–M1–A1–N1–T1–E1–H1, respectively, 
according to the classification proposed by Matthijnssens and colleagues (Matthijnssens et 
al., 2008b).
3.2. Analysis of VP7 nucleotide sequences
Phylogenetic analyses of the eleven genes determined the genetic relationships of the 
Cameroonian strains with a global collection of rotavirus genotypes. Phylogenetic analysis 
based on VP7 nucleotide sequences showed that all G9 strains detected in Cameroon during 
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1999–2000 clustered together in three distinct sub-clusters with lineage III G9 strains 
isolated worldwide (Fig. 1A). Nucleotide and amino acid identities among Cameroonian 
strains ranged between 88.6–100% and 84.6–100%, respectively. The strain RVA/Human-
wt/CMR/6788/1999/G9P[8] showed a maximum nucleotide identity of 90% with 
Cameroonian strains RVA/Human-wt/CMR/6806/1999/G9P[8], RVA/Human-wt/CMR/
6805/2000/G9P[8] and RVA/Human-wt/CMR/6796/2000/G9P[8], while its nucleotide 
identity with global G9 strains ranges from 81% to 89% (data not shown). Comparison of 
the amino acid sequence of strain RVA/Human-wt/CMR/6788/1999/G9P[8] to reference 
and contemporary human G9 genotypes from the GenBank revealed a low identity in the 
range of 81–85% as well as one to numerous substitutions in the nine major VP7 variable 
regions VR-1–VR-9 (Green et al., 1989) described for this protein (Fig. 2); VR-1 (I16L), 
VR-3 (A43 V), VR-4 (A68T), VR-5/antigenic epitope A (S90A, Q92E, G94A, and D100E), 
VR-8/antigenic epitope C (I208L, T210P, T212P, A213P, T214P, E217 K, and S221L), and 
VR-9/antigenic epitope F (D238E, T241P, T243P, and T245P) (Green et al., 1989; 
Kirkwood et al., 2003). The VR-2, VR-6 and VR-7 were highly conserved amongst both 
contemporary and older G9 strains. Substitutions in the three major variable regions; VR-5/
antigenic epitope A, VR-8/antigenic epitope C and VR-9/antigenic epitope F were mapped 
to the VP7 crystal structure of the RRV strain (G3P[3]) available in the Protein Data Bank 
(Fig. 3). Out of the 15 substitutions identified in these three regions, 11 were radical in 
nature. Radical changes are associated with changes in size, charge and polarity (Zhang, 
2000). Out of the 11 radical changes 9 were associated with changes in polarity with the 
strain 6788 being non-polar when compared to the consensus G9 strains. In VR-5/antigenic 
epitope A mutation in site 94 is associated with neutralization escape mutants (Aoki et al., 
2009). Similar sites associated with neutralization escape mutants were observed in VR-8/
antigenic epitope C (positions 213, 217, 221) and in VR-9/antigenic epitope F (position 
238). Comparative analysis of this strain with representative strains belonging to the major 
G9 VP7 lineages revealed a high similarity in the 5′ end of the gene and a lower similarity 
downstream of the central part of the gene (data not shown).
3.3. Analysis of VP4 nucleotide sequences
Evolutionary analysis of VP4 nucleotide sequences from Cameroonian strains and 
representatives of genotype P[8] from the Gen-Bank database demonstrated that strains from 
both regions of Cameroon grouped in four different sub-clusters of lineage P[8]-III together 
with other rotaviruses from around the world (Fig. 1B). Nucleotide (amino acid) identities 
between Cameroonian strains ranged between 95.4% and 100% (95.7–100%). Strain RVA/
Human-wt/CMR/6735/1999/G9P[8] showed a close genetic relationship with strains 
isolated in Acre-Brazil during 2005–2006 rotavirus season. Strain RVA/Human-wt/CMR/
6778/1999/G9P[8] grouped in a separate cluster together with a previously detected African 
P[8] strain. Two Cameroonian strains, RVA/Human-wt/CMR/6779/1999/G9P[8] and RVA/
Human-wt/CMR/6788/1999/G9P[8], showed complete identity with P[8] strains detected in 
Tunisia (North Africa) in 2002 and Cote D’Ivoire (West Africa) in 2004 (data not shown).
3.4. Analysis of VP1, VP2, VP3 and VP6 nucleotide sequences
Phylogenetic analysis based on VP1, VP2, VP3 and VP6 nucleotide sequences demonstrated 
that each gene of Cameroonian strains detected during the 1999–2000 rotavirus season 
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grouped in several separate clusters together with strains isolated worldwide (Fig. 1C–F). 
The Cameroonian strains showed a close genetic relationship with cognate gene sequences 
of previously reported G1P[8], G3P[8], and G4P[8] strains detected in the USA, Bangladesh 
and Belgium (McDonald et al., 2009; Mijatovic-Rustempasic et al., 2011; Rahman et al., 
2007). Nucleotide (amino acid) identity values among Cameroonian strains ranged from 
91.8–100% (94–100%), 90.7–100% (86.8–100%), 89.6–100% (93.9–100%), and 96–100% 
(99.2–100%) for VP1, VP2, VP3 and VP6, respectively. Complete nucleotide and amino 
acid similarity (100%) was shared between strains RVA/Human-wt/CMR/6735/1999/
G9P[8] and RVA/Human-wt/CMR/6795/1999/G9P[8] (VP1 gene); RVA/Human-wt/CMR/
6735/1999/G9P[8] and RVA/Human-wt/CMR/6779/1999/G9P[8], RVA/Human-wt/CMR/
6805/1999/G9P[8] and RVA/Human-wt/CMR/6806/1999/G9P[8], RVA/Human-wt/CMR/
6790/1999/G9P[8] and RVA/Human-wt/CMR/6792/1999/G9P[8] (VP2 gene); RVA/
Human-wt/CMR/6788/1999/G9P[8] and RVA/Human-wt/CMR/6805/1999/G9P[8] (VP3 
gene); and RVA/Human-wt/CMR/6806/1999/G9P[8] and RVA/Human-wt/CMR/
6807/1999/G9P[8] (VP6 gene). However, when the nucleotide and amino acid homologies 
of the VP1–VP3 and VP6 gene sequences of the Cameroonian strains were compared with 
cognate gene sequences of strains belonging to previously identified VP1–VP3 and VP6 
genotypes, all of them were more closely related to strains in the R1, C1, M1 and I1 
genotypes, respectively. Further comparison showed that within each genotype, the 
Cameroonian strains had maximum nucleotide (amino acid) identities of 84.8–98.6% (93.1–
99.4%) for VP1, 89.8–98.8% (89.8–99.8%) for VP2, 88.3–99.2% (91.4–99.5%) for VP3 and 
89.4–99.5% (97.5–100%) for VP6.
3.5. Analysis of NSP4 nucleotide sequences
Phylogenetic analysis based on NSP4 nucleotide sequences showed that the Cameroonian 
strains grouped into four different sub-clusters together with strains belonging to genotype 
E1 (Fig. 1G). The nucleotide (amino acid) identity among Cameroonian strains ranged 
between 90.9%-100% (94.3%-100%). Analysis of deduced amino acid sequences of 
Cameroonian strains and rotaviruses detected worldwide demonstrated that seven of the 
fifteen strains detected in Cameroon showed an amino acid substitution within the 
enterotoxin domain (aa 114–135) (Ball et al., 2005). Three strains exhibited changes at 
position H131Y and the other four at position N133S. Amino acid substitutions were 
observed within previously described antigenic sites (Ball et al., 2005; Borgan et al., 2003): 
ASIV (aa 1–24) at position L7 V; ASIII (aa 112–133) at positions H131Y and N133S; ASII 
(aa136–150) at positions I136A, P138S, V139A, V141I and I142V and ASI (151–169 aa) at 
positions E160N, S161N, and L169I when aligned with other E1 genotype strains (Fig. 4).
3.6. Analysis of NSP1- NSP3 and NSP5 nucleotide sequences
Phylogenetic analysis of NSP1- NSP3 and NSP5 nucleotide sequences, demonstrated that 
for each gene, the Cameroonian strains grouped in small separate sub-clusters of genotypes 
A1, N1, T1, and H1, respectively, together with other strains from around the world (Fig. 
1H–K). Nucleotide (amino acid) identity values among Cameroonian strains ranged from 
87.8–99.8% (82.9–99.7%), 86.8–100% (88–100%), 92.8–100% (93.1–100%) and 97.6–
100% (98.5–100%) for NSP1, NSP2, NSP3 and NSP5, respectively. Complete nucleotide 
and amino acid identity was shared between strains RVA/Human-wt/CMR/6777/1999/
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G9P[8] and RVA/Human-wt/CMR/6790/1999/G9P[8] (NSP2, NSP3 and NSP5 genes) and 
RVA/Human-wt/CMR/6806/1999/G9P[8] and RVA/Human-wt/CMR/6807/1999/G9P[8] 
(NSP3 and NSP5 genes), while only strains RVA/Human-wt/CMR/6779/1999/G9P[8] and 
RVA/Human-wt/CMR/6791/1999/G9P[8] were completely identical in their NSP5 gene 
sequences. However, when the nucleotide and amino acid homologies of the NSP1–NSP3 
and NSP5 gene sequences of the Cameroonian strains were compared with similar gene 
sequences of strains belonging to already identified NSP1–NSP3 and NSP5 genotypes, all of 
them were more closely related to strains in the A1, N1, T1, and H1 genotypes, respectively. 
Within each of these genotypes, the Cameroonian strains shared maximum nucleotide 
(amino acid) identity of 75.4–99.6% (68.7–98.8%), 81.2–99.5% (84.5–100%), 85.9–99.6% 
(87.9–100%), and 94.6–99.8% (93.9–100%), respectively.
4. Discussion
The genetic variability of RV-A strains is the result of accumulation of single nucleotide 
mutations (genetic drift) and sudden changes in the RV-A genome (genetic shift), primarily 
by reassortment and recombination events (Estes and Kapikian, 2007; Matthijnssens et al., 
2008c; McDonald et al., 2009; Ramig, 1997). Since the proposal that RV-A classification 
should be based on all 11 RV-A gene segments (Matthijnssens et al., 2008b), the number of 
studies reporting RV-A full genome sequences has increased (Banyai et al., 2011; Esona et 
al., 2010b, 2011; Matthijnssens et al., 2008a; McDonald et al., 2009, 2011; Mijatovic-
Rustempasic et al., 2011). Previous studies have shown that the predominance of a specific 
G type is related to the emergence of atypical VP7 lineages (Banyai et al., 2009; Parra, 
2009; Parra et al., 2005). The results obtained in this study revealed multiple amino acids 
changes in 6 of the 9 variable regions (Green et al., 1989; Kirkwood et al., 1993) when 
comparing Cameroon G9 strain RVA/Human-wt/CMR/6788/1999/G9P[8] to both 
contemporary and older G9 strains from the GenBank database. This suggests that this 
Cameroon G9 strain might represent a new genetic variant of VP7 gene G9 genotype. The 
relatively low overall amino acid homology with other G9 strains together with numerous 
changes in important antigenic regions raises questions on whether this strain may be 
antigenically distinct from typicalG9 strains. Also, the previously described conserved N-
glycosylation site found within VR-4 at amino acid residues 69–71 (Green et al., 1989) was 
found to be conserved in all G9 strains used in this analyses. Definitive conclusions on the 
possible origin of this variant could not be made by bioinformatics analysis of the VP7 gene 
sequence. However, in this case it remains unclear what selective pressures on this gene 
fragment could have driven this strong diversification, given that other gene segments of this 
strain retained their identity with related G9P[8] strains identified in the same region and 
time period. In this context, it is difficult to determine if a single sub-lineage of G9 can be 
responsible for the worldwide spread of G9 rotavirus as proposed recently (Matthijnssens et 
al., 2010).
At least six different neutralization epitopes (A through F) have been identified in the RVA 
VP7 protein, with A–C and F described as the most important (Kirkwood et al., 2003). The 
strain RVA/Human-wt/CMR/6788/1999/G9P[8] shows distinct changes in its antigenic 
regions when compared to G9 strains circulating in the same region and also globally (Fig. 
2). A strong shift in polarity, with strain RVA/Human-wt/CMR/6788/1999/G9P[8] being 
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strongly non-polar as compared to other G9 strains suggest possible inaccessibility of 
epitopes on the VP7 protein of strain RVA/Human-wt/CMR/6788/1999/G9P[8] as the 
region becomes more hydrophobic in nature. Multiple sites previously identified as 
important in producing neutralization escape mutants show substitutions in strain RVA/
Human-wt/CMR/6788/1999/G9P[8] when compared with global G9 strains. If strain RVA/
Human-wt/CMR/6788/1999/G9P[8] is also a neutralization escape mutant it could be due in 
part to changes in polarity at the antigenic epitopes. The amino acid sequences at positions 
87–101 and 208–211 (epitope region A and C) is said to be conserved within serotypes 
(Green et al., 1988). However, we observe substitutions within these regions in an alignment 
of a global collection of G9 strains.
Seven of the fifteen strains detected in Cameroon showed an amino acid substitution in the 
enterotoxin domain (114–135 aa) of NSP4. These changes occur at amino acid positions 131 
and 133, which are in the region (amino acid 131–140) reported to be responsible for altered 
pathogenesis mediated by the NSP4 protein (Zhang et al., 1998). Also observed are amino 
acid substitutions in the four previously described NSP4 antigenic sites (Ball et al., 2005). 
Antigenic sites AS IV, AS III, AS II and AS I had 1, 1, 5, 3 amino acids substitutions, 
respectively, when compared with strains in the E1 genotype. NSP4 is a trans-membrane 
glycoprotein known to be involved in virus assembly and is capable of inducing diarrhea in 
infant mice (Ball et al., 1996; Tian et al., 1996). It is possible these changes may affect the 
conformation or activity of NSP4 and also alter ability of host responses to neutralize 
enterotoxic function of the NSP4 gene segment (Ball et al., 1996; Tian et al., 1995).
Recent studies on origin and spread of the G9 rotavirus have revealed a high degree of 
genetic diversity within this genotype worldwide (Martinez-Laso et al., 2009; Phan et al., 
2007; Wu et al., 2011). These studies have also shown close similarity between human and 
porcine G9 strains and zoonotic transmission and convergent evolution were proposed as the 
possible evolutionary mechanisms. Studies in Brazil have implicated porcine G9 strains in 
many outbreaks (Leite et al., 2008). Also, reassortment events among animal and human 
strains have continued to be an important mechanism for rotavirus evolution and emergence 
in developing countries (Banyai et al., 2010; Esona et al., 2010b). This present report 
confirms the circulation of a diverse G9 genotype among children in two regions of 
Cameroon. However, all of the G9P[8] strains reported here showed close similarity in all 
gene segments except VP7 with human rotavirus strains of different G genotypes including 
G1P[8], G3P[8] and G4P[8]. Nonetheless, due to the increased close contact between human 
and animals in most developing countries, the full genome sequence data obtained from any 
future G9 study from Cameroon maybe entirely different.
Two live oral vaccines from Merck (RotaTeq®) and Glaxo-SmithKline (Rotarix®) have 
been licensed in more than 100 countries and are being introduced into routine 
immunization programs in several countries worldwide (Glass et al., 2006; Vesikari et al., 
2007), but has not been introduced in Cameroon. Therefore, it will be important to monitor 
the circulation of G9s in Cameroon before the introduction of these vaccines and, once 
introduced, to monitor the abilities of the vaccines to provide heterotypic protection against 
divergent G9 strains.
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Furthermore, monitoring temporal changes in all 11 gene segments may help us to 
comprehend the nature and pattern of rotavirus evolution. This study revealed the presence 
of a novel VP7 genetic variant and diverse G9P[8] strains in Cameroon. Surveillance to 
monitor the strain diversity of circulating RV-A to detect possible strain replacement 
following the introduction of universal RV-A vaccine is a priority of the World Health 
Organization. Such studies are important to estimate potential impact of vaccination 
programs on circulating strains including whether escape mutants of known serotypes or 
novel strains that evade vaccine immunity will emerge.
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A–K Maximum likelihood phylogenetic trees built in PhyML with aLRT statistics as 
support show the genetic relationships of nucleotide sequences of VP7 (A), VP4 (B), 
VP1(C), VP2 (D), VP3 (E), VP6 (F), NSP4 (G), NSP1 (H), NSP2 (I), NSP3 (J) and NSP5 
(K) of human G9P[8] rotaviruses from Cameroon with known human and animal rotavirus 
strains from GenBank database. The trees were drawn to scale. Only aLRT values of 70% 
and greater are shown. The strains labeled with filled squares indicate the Cameroon G9P[8] 
isolates sequenced in this study. The scale bar at the bottom of the trees indicates genetic 
distance.
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Comparison of the deduced amino acid sequence of gene segment 9 of strain RVA/Human-
wt/CMR/6788/1999/G9P[8] to a selection of older and contemporary G9 sequences from the 
GenBank. Only amino acids which differ are shown. Variable regions designated VR-1-
VR-9 are shown.
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Substitutions in strain RVA/Human-wt/CMR/6788/1999/G9P[8] highlighted on the crystal 
structure of RRV VP7 protein (3fmg). The molecule is colored in green. Residues 
corresponding to previously describe major antigenic sites A, C and F are indicated in red, 
blue and orange spheres, respectively. Arrows indicate substitutions at amino acid positions. 
(For interpretation of the references to colour in this figure legend, the reader is referred to 
the web version of this article.)
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Alignment showing amino acid substitutions inside the four NSP4 antigenic sites of the 
Cameroon G9 strains.
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